Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: April 1st – Prostatitis Do It For Dads Walk/Run – Father’s Day 2016 Jan. 2016 Awareness Night – Dr. Shabbir Alibhai discusses Androgen Deprivation Therapy (ADT) in detail Ask the Doctor – Dr. Danny Vesprini: Does Prostate Cancer ‘Run in the Family’? Board News Bowling Night for our volunteers Revision of PCCN-Toronto governance guidelines The Navigator Project Hospital counselling The 2016 awareness nights schedule Read it by clicking the link below to open the pdf file: March_2016_Newsletter
In a small study of men with prostate cancer, researchers found a novel agent combined with positron emission tomography (PET) imaging detected 97% of cancerous lesions. Read the article.
Recent epidemiologic evidence suggests that higher circulating 25-hydroxyvitamin D does not protect against prostate cancer and, in fact, may increase the risk of developing this malignancy. However, few studies have examined the most clinically relevant outcome, prostate cancer mortality. This study showed in a population of men diagnosed with prostate cancer, higher serum 25(OH)D years prior to diagnosis was associated with longer prostate cancer survival. Read the article.
Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy
The association between obesity and aggressive forms of prostate cancer is controversial. A study compared preoperative body mass index (BMI) and prostate-specific antigen (PSA) levels as predictive risk factors for increased prostate weight and disease aggressiveness. Higher BMI was associated with higher prostate weight and PSA, as well as with higher pT stage and pathologic GS in men undergoing radical prostatectomy, providing further evidence that obese men are more likely to have aggressive cancer. BMI thus constitutes an additional risk factor besides PSA. Read the article.
Significant cost variations existed between competing treatments for low-risk prostate cancer from the time of diagnosis through treatment, according to the results of a time-driven activity-based costing analysis. Read the article.
Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today. Read the article.
Two papers from University College London show that having early chemotherapy improves survival for men with prostate cancer. Read the article.
A survey showed men who underwent radical prostatectomy, especially robotic radical prostatectomy, had unrealistic expectations about how well they would function sexually postoperatively. Read the article.
A new genomic test, Oncotype DX, gauges how lethal a tumor is by looking at the expression of 17 genes in the tumor. Read the article.
Click here to view, in cartoon form, some of our basic tips for all of your visits. (You have to click on the row of cartoons to view them.)